SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
The FDA has selected seven companies for the new PreCheck Pilot Program to strengthen domestic drug manufacturing and supply chain resilience. This initiative aims to boost America…
Plum Acquisition Corp. IV has rescheduled its extraordinary general meeting from July 2 to July 10, 2026. The postponement also extends the redemption deadline to July 8, giving sh…
TerrAscend Corp. filed a preliminary proxy statement for a Special Meeting voting on a 5-to-20 share consolidation ratio. The move is intended to allow the cannabis operator to sat…
High Roller Technologies announced its subsidiary ROLR US LLC received regulatory approval from the National Futures Association to launch prediction markets. This milestone grants…
DBV Technologies anticipates filing its Biologics License Application for the VIASKIN Peanut Patch in children aged 4 through 7 years in Q3 2026. The company received guidance to r…
Synergy CHC Corp. filed to amend its 2024 Equity Incentive Plan, raising the share pool to 150 million shares and granting the board authority to modify outstanding awards without …
WinVest Acquisition Corp.'s legal counsel BCRG Group confirms its agreement with the disclosure statements made in the June 23, 2026 Form 8-K. This validation supports compliance w…
NRC Health filed its First Amended and Restated Certificate of Incorporation with the Delaware Secretary of State, restating the company's capital structure. This administrative up…
The submitting entities filed a Form 8-K current report with the SEC, disclosing administrative address details and corporate registration information.
Replimune announced fiscal 2026 financial results and confirmed the FDA accepted its resubmission of the BLA for RP1 in combination with nivolumab for advanced melanoma with a goal…
Neurogene announced 30-month data showing participants significantly gained developmental milestones without plateauing or loss, demonstrating a durable therapeutic effect. This po…
Barrel Energy Inc. filed an exhibit (3.1) to amend a designation of preferred stock. The specific terms of the amendment were not visible in the provided file header.
Regenerxbio announced the first patient dosed in the NAAVIGATE trial and received a $100 million milestone payment from AbbVie. This milestone highlights progress in potential one-…
Larimar Therapeutics has submitted the first module of its rolling BLA to the FDA seeking accelerated approval for nomlabofusp. This submission supports the company's goal for mark…
Viridian Therapeutics announced the FDA approval and immediate launch of Lumvoa for thyroid eye disease. This makes Lumvoa the first approved treatment for both active and chronic …
Matinas BioPharma received notice of non-compliance with NYSE American listing standards due to falling below stockholders' equity requirements. The exchange accepted the company's…
Upexi, Inc. has been added to the Russell Microcap Index effective Monday. The inclusion broadens visibility among institutional investors and index funds.
HP Inc. filed an exhibit containing its amended and restated bylaws, which outline specific procedures for shareholder meetings and nominations. This update primarily defines the c…
Summit Group CPAs, P.C. confirmed agreement with statements in the company's recent filing. This routine submission establishes compliance with executive compensation reporting sta…
Ernst & Young authorized the use of their audit report within Stryker's current filing to support the financial statements section. This procedural move facilitates the incorporati…